ArticleOncoTargets and therapy2018

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.

Xiaomin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.